Skip to main content
Clinical Trials/JPRN-UMIN000007859
JPRN-UMIN000007859CompletedPhase 3

nilateral versus bilateral endoscopic biliary drainage for unresectable malignant hilar obstruction: a multicenter randomized controlled trial (BRILLIANT Trial) - Unilateral versus bilateral endoscopic biliary drainage for unresectable malignant hilar obstruction: a multicenter randomized controlled trial (BRILLIANT Trial)

Japanese Endoscopist & IVRists group for Biliary Tract Cancer (JEIBIC)0 sites166 target enrollmentStarted: May 1, 2012Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
166

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) Patients after gastrectomy with Roux-en-Y reconstruction or Billroth II reconstruction. 2) Patients with marked hemiliver atrophy or patients after hepatectomy. 3) Separate obstructions of fourth-order or smaller biliary branches. 4) Patients with severe acute cholangitis. 5) Pregnant or breast-feeding women. 6) Patients considered ineligible for this study.

Investigators

Sponsor
Japanese Endoscopist & IVRists group for Biliary Tract Cancer (JEIBIC)

Similar Trials